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resumen
La glándula prostática es regulada por hormonas 
esteroides, sus complejas interacciones están en un 
delicado balance regulando el crecimiento y desarrollo 
de la glándula. Interesantemente, los cambios en las 
concentraciones de hormonas esteroides durante la 
edad senil afectan el equilibrio hormonal y contribuyen 
con la evolución de los cambios patológicos de esta. 
En este trabajo se ha analizado el efecto del letrozol, 
un inhibidor de la enzima aromatasa, sobre la 
estructura de la próstata ventral de animales intactos 
y de animales castrados. Los resultados demuestran 
alteraciones en la fi siología de la glándula después del 
tratamiento con letrozol: las concentraciones sericas 
de testosterona, el peso de la glándula y los índices 
de proliferación de las células epiteliales y luminales 
aumentaron. Las concentraciones de estrógeno no 
fueron alteradas dramáticamente, en contraste fue 
observado el aumento de las concentraciones de 
las gonadotrofi nas en los animales castrados. La 
castración no altero el índice de proliferación de las 
células basales. En los animales tratados con letrozol 
fue observada la reorganización de los diferentes 
compartimentos como el epitelio y estroma. Además, 
una disminución de la expresión del receptor de 
andrógeno fue observada en los animales después de 
21 días del tratamiento con letrozol. Estos resultados 
fueron confi rmados con inmunocitoquimica. Los 
anteriores resultados revelan aspectos nuevos de 
la relación entre el receptor de andrógeno y el 
metabolismo del estrógeno en la glándula prostática, 
demostrando que alteraciones en las concentraciones 
hormonales durante un corto periodo de tiempo 
pueden inducir alteraciones signifi cativas en el 
equilibrio de la glándula prostática.
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abstract
The prostate gland is regulated by steroid hormones 
and complex interactions based on a subtle balance 
between androgen and estrogen (E2) regulate 
prostatic development and physiology. Interestingly, 
the changes in steroid hormone levels at old ages 
affect the hormonal milieu and contribute to the 
evolution of the pathological changes of the gland. We 
have analyzed the effects of letrozole, an aromatase 
inhibitor, on the structure in the ventral prostate 
of control and castrated adult rats. The results 
demonstrated alterations in prostate physiology after 
letrozole treatment. Serum levels of testosterone, 
prostate weight and proliferative index in luminal 
and basal cells were increased. Estrogen serum 
levels were not altered dramatically, in contrast to 
slight increase in gonadotrophin hormones seen in 
the castrated animals. Castration did not alter the 
proliferation index of basal cells. Reorganization 
letrozole effect in murine ventral prostate 
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of tissue compartments was seen with significant 
increase in letrozole treated animals. A decrease in 
androgen receptor expression was seen 21-days after 
the beginning of treatment with letrozole. These results 
were confirmed by immunohistochemistry. These results 
reveal new aspects in the relationship between androgen 
receptor and steroid metabolism in the prostate gland, 
demonstrating that alteration in hormone levels during 
a short time period induces significant alterations in 
prostate homeostasis.
Key words
prostate, androgen receptor, letrozole, cell proliferation
introduction
Prostate development is primarily influenced by 
androgens; testosterone (T) and its active metabolites 
elicit regulatory responses of urogenital sinus (UGS) from 
epithelial bud induction up to the total differentiation 
and functional maturity. However, prostate is also 
an estrogen-targeted organ and the expression of the 
estrogens receptors, α and β, in prostate gland together 
with the presence of enzymes involved in estrogen 
metabolism suggest important role of this hormone in 
differentiation and metabolism of prostate gland1,2,3. 
The biosynthesis of estrogens occurs via metabolism of 
an androgenic substrate and the enzyme involved in the 
irreversible transformation of androgen in estrogens is 
a complex known as aromatase, which is present in the 
endoplasmic reticulum of numerous tissues4, including 
the prostate gland, suggesting a direct intraprostatic 
effect of estrogen5. The aromatase complex is composed 
of two proteins; the NADPH-cytochrome p450 reductase 
and a cytochrome p450 aromatase, which contains 
the heme and the steroid binding pocket6. In humans, 
the p450arom is the product of a single Cyp19 gene, 
belonging to the cytochrome p450 family7.
The aromatase-modulated transgenic mice, such as 
the aromatase-overexpressing (AROM+) mouse and 
the aromatase-knockout mouse (ArKO) allowed the 
determination of the effects of estrogen/androgen 
unbalance in male reproductive functions 4,8. From 
these effects, it is remarkable the prostate atrophy 
in AROM+ mice and prostate enlargement, elevated 
peripheral and intraprostatic androgen levels and 
increased androgen receptor expression in ArKO 
mice9.
Other important alterations are age-dependent changes 
in the hormonal balance, marked by a decrease in 
serum testosterone to estradiol ratio, when coupled with 
alterations in the concentrations of steroid receptors, 
may contribute to the evolution of pathological changes 
observed in benign prostatic hyperplasia (BPH) and 
carcinoma of prostate gland among older men10. 
As shown in other reports, androgen receptor is 
expressed along the entire prostatic ducts in all three 
lobes from adult rats where it elicits the different 
responses after T and DHT exposure11, 12. Many 
studies are focused in the altered pattern of expression 
after exogenous compounds. For example, the normal 
developmental of the rat prostate lobes is affect by 
exposure of the neonatal animals to estrogens resulted 
in an altered pattern13. The purpose of this study was to 
investigate the effect of letrozole, an aromatase inhibitor, 
on androgen receptor expression in the ventral prostate 
structure and androgen receptor expression of the 
non-castrated and castrated rats, aiming at identifing 
processes that affect AR levels and AR function, and 
that might thereby influence proliferation and viability 
of androgen dependent cells.
materials and metHods
treatMents
A total of 40 male Wistar rats (12 weeks old) were housed 
in standard plastic cages, maintained under controlled 
conditions (lights on 0700-1900h, temperature 20-24 
oC) and allowed to water and rat chow ad libitum. 
The rats were divided into ten different groups: intact 
rats (Control), non-castrated rats treated with letrozole 
during seven days (LET 7), castrated letrozole-treated 
rats (CASLET) and castrated (CAS) with no further 
treatment. Analyses were performed 7, 14 and 21 days 
after treatments. Treated rats received 1 mg/kg/day 
of aromatase inhibitor, letrozole, dissolved in corn 
oil by oral gavage14. This dose has been previously 
demonstrated to produce a significant decrease in 
the concentration of estrogen in the serum of female 
rats15. Control rats received the same volume of the 
vehicle. Animals were killed by cervical dislocation. 
The prostates were removed, and ventral prostate (VP) 
were dissected. For immunohistochemical studies, VPs 
were fixed in 4% paraformaldehyde and embedding in 
paraffin. The experiments were carried out according 
to the Guide for Care and Use of Laboratory Animals 
and were approved by the Committee for Ethics in 
Animal Experimentation.
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cheMicals and antibodies
Letrozole was purchased from Novartis (Basileia, Swiss), 
corn oil and protease inhibitor cocktail, were obtained 
from Sigma Chemical Co. (St Louis, MO, USA). 
Monoclonal mouse anti-Ki67 antibody was purchased 
from Dako (Carpentaria, CA, USA). Anti-AR rabbit 
polyclonal anti-AR (N-20) primary antibody and 
luminal reagent were from Santa Cruz Biothecnology 
(Santa Cruz, CA. USA) and The EasyPath ABComplex/
HRP kit from Novocastra Laboratories (Newcastle 
upon Tyne, UK). 
horMone MeasureMent
Plasma levels of testosterone (T), estradiol (E2), 
luteinizing hormone (LH) and follicle stimulating 
hormone (FSH) were estimated by RIA. Blood samples 
were obtained by cardiac puncture immediately before 
death. The plasma was separated by centrifugation and 
stored at -20 C for subsequent hormone assays. T and E2, 
concentrations were measured in serum samples using 
Coat-a-count kits (Diagnostic Products, LA, CA, USA). 
Serum samples were assayed in duplicate. 
Plasma LH and FSH were measured by double-antibody 
radioimmunoassay using specific kits provided from 
the National Hormone and Peptide Program (NIH / 
NIDDK, USA). All samples in the same experiment 
were measured in the same assay. The lowest detectable 
amount of LHRP3 standard was 0.05 ng/ml and the 
intra-assay coefficient of variation was 4%. The lowest 
detectable amount of FSHRP2 standard was 0.2 ng/ml 
and the intra-assay coefficient of variation was 3.2 %. 
histoloGy 
The VP was immediately fixed by immersion in 4% 
formaldehyde in phosphate-buffered saline (PBS) for 24 
hr. Samples were then washed, partially dehydrated 
and embedded in Leica historesin. Two micrometer 
sections were obtained and stained with hematoxylin 
and eosin 16.
iMMunohistocheMical localization  
oF androGen recePtor 
Paraffin-embedded sections (6 µm) of VP were dewaxed 
and rehydrated in an ethanol graded series. Antigens 
were retrieved by boiling in 10 mM citrate buffer (pH 6.0) 
3 times of 5 min. The cooled sections were incubated in 
1% H2O2 for 15 min to quench endogenous peroxidase. 
To block nonspecific binding, sections were incubated in 
BSA 3% for 1h at room temperature. Sections were then 
incubated with anti-AR (1:100) or anti-Ki67 (1:100) in 1% 
BSA at 4°C. Negative controls were incubated with 1% 
BSA without primary antibody. The ABC kit was used to 
visualize the signal, according to manufacturer’s manual. 
The sections were incubated in appropriated secondary 
antibody solution for 30 min followed by washing for 10 
min with PBS and incubation in Avidin and Biotinylated 
HRP solution for 30 min. After washing in PBS, 
sections were developed with 3, 3´diaminobenzidine 
tetrahydrochloride substrate, lightly counterstained with 
methyl green, dehydrated through ethanol series and 
xylene, and mounted.
countinG oF ProliFeratinG cells 
To quantify and compare proliferation rates between 
VP of control and treatments groups, dividing cells were 
assessed by counting Ki67-positive and Ki67-negative 
(methyl green-stained) nuclei at 400 x magnification. A 
total of three immuno-stained sections per treatment 
were used. Separated counts were made for the epithelial 
and stromal compartments of the gland. Approximately 
2,000 cells were counted for each treatment. The number 
of positive cells was expressed as the percentage of Ki67-
positive cells.
statistical analysis
Body weights, tissue weights, hormone serum levels (T, E2, 
LH and FSH), stereological data, cell proliferation and 
cell death index, were analyzed for statistical significance 
by analysis of variance (ANOVA). Comparisons among 
individual treatments conditions within each time period 
were further examined by Tukey’s test for multiple 
comparisons using MINITAB® Release 14.20. Results 
were considered to be statistically significant when 
p<0.05.
results
body and orGan weiGhts
Body, prostate, and relative testis were not affected by 
letrozole treatment (Table 1). 
After seven days, castration led the prostate to a 70% 
regression. After 14 and 21 days of castration the 
regression was 80%. The letrozole administration in 
castrated rats did not alter this effect. 
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seruM horMones concentrations 
Testosterone levels were altered after treatment with 
letrozole during the 14 day of the experiment (Table 2). 
At seven and 21 days of treatment the intact rats 
did not present significative alterations when 
compared with the control. In castrated animals 
(treated or not with letrozole) T levels were below to 
detection level. LH and FSH levels in control group 
were 3.8 ± 0.7 and 8.7 ± 1.6, respectively. Letrozole 
treatment did not affect these values. However there 
was a tendency in castrated animals for increased 
gonadotrophin levels. Serum estrogen levels were 
stable in all treatments.
tREAtMENt DAy BODy WEIGht (G) pROStAtE (MG)
RELAtIVE  
pROStAtIC WEIGht
tEStIS (G)
CoNtRoL 336.75 ± 16.66 305.08 ± 30.67 0.090 ± 0.00 3.73 ± 0.07
LEtRoZoLE
7 327.50 ± 13.67 340.68 ± 21.61* 0.104 ± 0.00 3.59 ± 0.13
14 314.75 ± 7.97 293.20 ± 32.83 0.093 ± 0.00 3.36 ± 0.14
21 329.75 ± 25.41 330.73 ± 21.24 0.101 ± 0.00 3.36 ± 0.11
CAStRAtED
7 317.25 ± 6.40 87.05 ± 18.51* 0.027 ± 0.00* _
14 330 ± 21.09 33.58 ± 5.52* 0.010 ± 0.00* _
21 326.50 ± 19.77 34.53 ± 8.19* 0.010 ± 0.00* _
CAStRAtED PLUS 
LEtRoZoLE
7 340.50 ± 25.51 74.73 ± 15.56* 0.022 ± 0.00* _
14 312 ±12.33 38.23 ± 13.69* 0.012 ± 0.00* _
21 331 ± 20.30 32.43 ± 8.83* 0.009 ± 0.00* _
table 1. Body, prostate, relative prostate, and testis weight in grams, of adult rats after treatment with different drugs 
(values are given as means ± SEM n=4). 
tREAtMENt DAy
tEStOStERONE 
(NG/DL)
EStRADIOL (pG/
ML)
Lh (NG/ML) FSh (NG/ML)
CoNtRoL 308.8 ± 29.35 16.64 ± 1.73 3.8 ± 0.68 8.65 ± 1.64
LEtRoZoLE
7 364.78 ± 15.80 23.45 ± 1.12 5.15 ± 0.71 10.9 ± 0.89
14 625 ± 72.50 19.84 ± 2.10 5.73 ± 0.99 16.63 ± 2.09
21 359 ± 55 24.65 ± 0.31 7.3 ± 0.58 9.53 ± 0,66
CAStRAtED
7 _ 20.69 ± 1.73 6.5 ± 0.72 24.18 ± 2.41
14 _ 23.93 ± 0.68 10 ± 0.43* 22.50 ± 0.31
21 _ 21.69 ± 4.08 12 ± 0.60* 53.50 ± 2.10*
CAStRAtED
PLUS LEtRoZoLE
7 _ 10.74 ± 0.22 10.8 ± 0.20* 38.8 ± 7.60*
14 _ 12.04 ± 1.18 6.6 ± 0.56 46.30 ± 2.79*
21 _ 17.64 ± 0.02 10.25 ± 0.92* 40.90 ± 9.85*
* = p< 0.05, as compared to the control
* = p< 0.05, as compared to the control
table 2. Serum testosterone, Estradiol, Luteinizing hormone and Follicle stimulating hormone levels of adult rats after 
treatment with different drugs (values are given as means ± SEM n=4). 
histoloGical analyses 
Examination of ducts in rat ventral prostate of adult rats 
(91-day-old) revealed a simple columnar epithelium, 
lined with tall columnar secretory epithelial cells (Fig. 
1A)
The characteristic infolding of the distal region is also 
present (Fig. 1B). After 7 (Fig. 1C), 14 (Fig. 1D) and 21 
(Fig. 1E) days of beginning of treatment the proximal 
ductal region did not show differences when compared 
to the control. The proximal region of letrozole-treated 
animals in 7th day presented small vesicles in the layers 
of stromal cells (Fig. 1C), and proximal regions of 
the 21st day presents a multilayered sheet of smooth 
muscle cells. However in absolute terms, a decrease 
of the smooth muscle cell was detected in the 7th and 
21st but not in 14th day of treatment. Intermediate 
ductal regions (Figs. 1F-H) did not show significative 
alterations between treatments. Distal ductal regions 
presented pronounced mitotic activity (Figs. 1I-K), 
particularly in the 7th day after treatment absolute 
values of epithelium and lumen were increased and, 
after 21st days, there was a stimulatory effect only in 
the luminal compartment. 
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After seven days of castration, the prostate remodeled 
dramatically losing its characteristic morphology. 
The epithelial regression is evident and stromal cells 
became disorganized. In castrated rats (Fig. 1L) and 
castrated-letrozole treated rats (Fig. 1M) different 
patterns of smooth muscle cells were seen. After 14 
days of castration the frequency of rudimentary 
ducts increase in the prostatic area and the stromal 
cells are more evident (Fig. 1N). Letrozole-treated 
rats conserved this pattern (Fig. 1O). After 21 days 
of castration the acini were totally atrophic and 
their frequency was increased. (Figs. 1P and Q). 
No alteration was seen in the smooth muscle cell 
compartment. 
Figure 1. the morphology of control, letrozole-treated, castrated and castrated letrozole-treated rats was examined by 
H&E staining after seven days of treatment with letrozole, and then collected after 7, 14 and 21 days of the beginning of 
treatment. A and B, control animals showing the active columnar epithelium and the characteristic infolding of the distal 
region (arrow). 
Proximal, intermediate and distal region of letrozole-treated animals after 7, (C, F and I), 14 (D, G and I) and 21 (E, H and 
K) days of the experiment. the proximal regions of the treatments show different characteristics in the stromal 
compartment (arrow). Intermediate regions conserved the same morphological organization and distal regions 
present intense proliferate activity (arrows)
Castrated animals after seven days (L) and treated with letrozole (M) present an epithelial regression. It was 
also notable different patters in the stromal cells pattern (inset). After 14 days of castration the atrophied acini, 
in detail apoptotic figure (N) the treatment with letrozole present disorganization in an epithelial and stromal 
comparments (o). 21 days after castration the acini are reduced and the stroma is a predominant compartment 
(P) treatment with letrozole did not alter this pattern (q). Apparently the letrozole treatment in castrated rats 
results in a dense cellular stromal phenotype. Lu = lumen; smc = smooth muscle cell, St = stroma.
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iMMunolocalization oF androGen  
recePtor in ventral Prostate lobes 
In control rats the total epithelial cells were AR-
positive (Fig. 2A) and staining was also present in 
some stromal cells (Fig. 2B). The distal ductal region 
showed AR- positive cells with different intensity 
staining (Fig. 2C). In letrozole-treated groups, in the 
7th  (Figs. 2D, G and J) and 14th day (Figs. 2E, H, 
and K) the AR-staining in proximal, intermediate 
and distal regions of the prostate was not modified. 
The main alteration in letrozole treated animals was 
found in 21-day group that showed a decrease in a 
staining in the three regions of ventral prostate. In 
the proximal region there was a decrease in staining 
in epithelial and stromal cells (Fig. 2F). In the 
intermediate and distal regions AR-staining was 
decreased (Fig. 2I) in the epithelial cells (Fig. 2L). 
Castration had a strong effect on AR-staining, which 
was completely abolished. Letrozole application did 
not alter this pattern (Fig. 2B).
Figure 2. Histological sections of the rat ventral prostate immunocytochemically stained for AR. In the control 91 day-old rats 
(2A-C) most of the epithelial cells within the acini were AR (+) (arrows). It was detected a presence of the stromal cells AR- positive 
(arrow).
In the animals treated for seven days with letrozole the epithelium showed a strong nuclear staining in the proximal, intermediate 
and distal region (D, G, and J) respectively. Fourteen days after treatment a intense staining was seen in proximal region (E), while 
intermediate (H) and distal regions (K) conserve the staining. 21 days (F, I and L), the intense of the nuclear staining was fainter 
(arrows) staining decrease in the different regions. 
Immunocytochemical localization of AR in the prostate of castrate rats. the epithelial cells showed only a weak staining. 
Neither nucleus nor cytoplasm was stained seven days after castration (M). In castrated letrozole-treated rats after 
seven days the nucleus and cytoplasm were weakly labeled (P). Fourteen (N) and twenty-one days (o) after castration, 
the epithelial cells were atrophic and the stroma was more evident. Labeling was abolished. treatment with letrozole 
did not alter this pattern (q and R). (Figs. 2B, 2D, 2F, 2H, 2L (925x)). Lu = lumen; smc = smooth muscle cell, st=Stroma 
Ki67 Positive cell 
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counts
To assess the proliferative status of the basal and 
luminal compartments, the expression of the Ki67 
antigen was measured. After seven days of treatment 
an increase in the proliferation index in basal cells of 
letrozole-treated animals was observed (Figure 3). 
Figure 3. Box-plot representations of the median percentage 
of Ki67 positively stained cell in luminal (A and B) and stromal 
(C) compartments. the experimental groups are sequentially 
represented according to the different treatments. the plots 
correspond to counts of 20 separate fields of view from each 
experimental group. Ct=Control; LEt= Letrozole-treated 
animals; CASt= Castrated animals; CAStLEt=Castrated 
letrozole treated animals
Fourteen and 21-days after treatment, the proliferative 
index was similar to that of control animals. After 
seven days of castration the proliferative index 
changed from 2.46% in luminal cells to 0.40%. 
However these values were not significative. At 
the 14th and 21st day not proliferative activity 
was detected in the epithelial compartment. Ki67 
staining was detected after seven days of castration 
in basal cells. Treatment with letrozole in castrated 
rats did not alter this pattern. The prostate of 
castrated and castrated-letrozole treated animals 
were Ki67 negative. 
discussion
Multiple examples of physiological interplay between 
androgens and estrogens led us to hypothesize that 
there may be a direct interaction between the androgen 
receptor and estrogen receptors. In breast cancer for 
example, tumors containing both receptors (AR and 
ER) presented higher levels of endogenous steroid 
hormones than tumors showing either receptor 
alone17.
In prostatic tissue, androgen receptor (AR) synthesis 
is regulated by androgens. Therefore, it might 
serve as an effective molecular marker of androgen 
action in this tissue. In this study we showed that a 
deregulation of hormonal environment alters the 
normal expression of AR and interfere with the 
kinetics of cell proliferation. 
Previous reports showed a relationship between 
AR and aromatase inhibitors. A breast cancer cell 
(MCF-7) was sensitive to aromatase inhibitors and 
blockade of the AR inhibited the antiproliferative 
effect of letrozole. These results suggest that aromatase 
inhibitors might exert their antiproliferative effect 
not only by reducing the intracellular production of 
estrogens but also by unmasking the inhibitory effect 
of androgens acting via the AR18. In the present study 
letrozole did not cause an inhibiting effect on the 
proliferating cells. On the contrary, a slight increase 
of proliferating cells was present which led us to 
hypothesize that an inhibition of the conversion of T 
to E2 by letrozole resulted in a significant increase in 
serum T levels as well as in alterations in the pattern of 
AR location, thus demonstrating that its expression is 
dependent on the hormonal environment and probably 
control cell proliferation. This inhibition of estrogen 
synthesis by letrozole was effective and the hormonal 
quantifications showed larger levels of testosterone 
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serum levels after treatment. The general tendency 
of an increased epithelial and luminal compartments 
and a decrease of the stromal compartment indicate 
a reorganization of the gland after disruption of the 
normal hormonal environment, besides an increase 
in proliferation index of the basal cells.
Variation in normal AR synthesis among the different 
treatment groups was noted, with the highest levels 
seen in the VP of control rats and the expression of 
the AR-staining shows a quick effect in AR-labeling 
in animals treated after 14 and 21 days.
The possible pathways activated after letrozole 
treatment was the increase of testosterone levels, 
after aromatase inhibition that stimulates the cell 
proliferation and produces the growth in the tissue 
compartments of the gland. Cell proliferation is also 
stimulated by the loss of the physiological ligands of 
estrogen receptors, as demonstrated by Weihua and 
co-workers19 Androgen receptor down regulation 
likely results from the disruption of the hormonal 
milieu.
We conclude that letrozole down-regulates AR in 
the rat ventral prostate and alters the serum levels 
of androgens. This model represents a valuable 
model for analyzing the direct and indirect effects of 
unbalanced estrogen and androgen action.
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